Compass Therapeutics(CMPX) - 2019 Q4 - Annual Report
Compass Therapeutics(CMPX)2019-07-02 02:50
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 82-4876496 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Title of Each Class Trading Symbol Name of Each Exchange on Which Registered N/A N/A N/A FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ...